1
How To Look at Alternatives in the Middle of Market Volatility?
Sam Bourgi
|
Appetite for alternatives, which includes hedge funds, real estate, and precious metals, has...
Welcome to MutualFunds.com
Please help us personalize your experience and select the one that best describes you.
Your personalized experience is almost ready.
Thank you!
Check your email and confirm your subscription to complete your personalized experience.
Thank you for your submission
We hope you enjoy your experience
Fixed income news, reports, video and more.
Municipal bonds news, reports, video and more.
Practice management news, reports, video and more.
Portfolio management news, reports, video and more.
Retirement news, reports, video and more.
Learn from industry thought leaders and expert market participants.
Deepen your understanding of Responsible Investing and learn how it can potentially help you build a more successful practice.
18 Most Popular Mutual Fund Categories
View All Categories
15 Most Popular Fund Company Quick Screens
View All Fund Company Quick Screens
Receive email updates about fund flows, news, upcoming CE accredited webcasts from industry thought leaders and more.
Content focused on helping financial advisors build successful client relationships and grow their business.
Content geared towards helping financial advisors build better client portfolios.
Get insights on the industry trends and investment news from leading fund managers and experts.
The company reported earnings of $1.835 billion, or $1.79 per share, up from $55.4 million, or 6 cents per share, last year. Analysts expected to see EPS of 7 cents.
Revenue
Revenue increased to $6.85 billion from $6.60 billion last year. Analysts expected to see revenue of $6.80 billion.
Outlook
Looking ahead, RAD expects to see FY2016 EPS between 19 cents and 27 cents.
Like other drug companies, Rite Aid is expanding its pharmacy and wellness business to boost sales. During the quarter, prescription sales grew 3.5%; this business segment accounted for 68.1% of total sales.
| Symbol | Mutual Fund | Stake |
|---|---|---|
| RPMGX | T. Rowe Price Mid-Cap Growth | 2.80% |
| PRHSX | T. Rowe Price Health Sciences | 2.31% |
| NAESX | Vanguard Small Cap Index | 1.81% |
If you’ve enjoyed this article, sign up for the free MutualFunds.com newsletter; we’ll send you similar content weekly.
Receive email updates about best performers, news, CE accredited webcasts and more.
Sam Bourgi
|
Appetite for alternatives, which includes hedge funds, real estate, and precious metals, has...
We are tackling the topics of choosing the right webinar topic, finding balance...
We will take a closer look at how credit rating agencies are assessing...
Find out why $30 trillon is invested in mutual funds.
Download our free report
Find out why $30 trillon is invested in mutual funds.
Download our free report
Find out why $30 trillon is invested in mutual funds.
Mutual Fund Education
Justin Kuepper
|
Let's take a closer look at how ESG investments have outperformed during the...
Mutual Fund Education
Daniel Cross
|
While CITs and mutual funds share many similarities, there are some key differences...
Mutual Fund Education
Sam Bourgi
|
The phrase ‘bear market’ has been thrown around a lot lately, but it...
The company reported earnings of $1.835 billion, or $1.79 per share, up from $55.4 million, or 6 cents per share, last year. Analysts expected to see EPS of 7 cents.
Revenue
Revenue increased to $6.85 billion from $6.60 billion last year. Analysts expected to see revenue of $6.80 billion.
Outlook
Looking ahead, RAD expects to see FY2016 EPS between 19 cents and 27 cents.
Like other drug companies, Rite Aid is expanding its pharmacy and wellness business to boost sales. During the quarter, prescription sales grew 3.5%; this business segment accounted for 68.1% of total sales.
| Symbol | Mutual Fund | Stake |
|---|---|---|
| RPMGX | T. Rowe Price Mid-Cap Growth | 2.80% |
| PRHSX | T. Rowe Price Health Sciences | 2.31% |
| NAESX | Vanguard Small Cap Index | 1.81% |
If you’ve enjoyed this article, sign up for the free MutualFunds.com newsletter; we’ll send you similar content weekly.
Receive email updates about best performers, news, CE accredited webcasts and more.
Sam Bourgi
|
Appetite for alternatives, which includes hedge funds, real estate, and precious metals, has...
We are tackling the topics of choosing the right webinar topic, finding balance...
We will take a closer look at how credit rating agencies are assessing...
Find out why $30 trillon is invested in mutual funds.
Download our free report
Find out why $30 trillon is invested in mutual funds.
Download our free report
Find out why $30 trillon is invested in mutual funds.
Mutual Fund Education
Justin Kuepper
|
Let's take a closer look at how ESG investments have outperformed during the...
Mutual Fund Education
Daniel Cross
|
While CITs and mutual funds share many similarities, there are some key differences...
Mutual Fund Education
Sam Bourgi
|
The phrase ‘bear market’ has been thrown around a lot lately, but it...
TAXATION
For mutual fund investors, taxes are inevitable. Even if you’re a long-term buy...
MUTUAL FUND EDUCATION
Many investors assume that changes in a mutual fund’s net asset value (NAV)...
MUTUAL FUND EDUCATION
For investors looking to add mutual funds to their portfolio, they need to...
Receive email updates about best performers, news, CE accredited webcasts and more.
Disclaimer: By registering, you agree to share your data with MutualFunds.com and opt-in to receiving occasional communications about projects and events. The contents of this form are subject to the MutualFunds.com Privacy Policy. You can unsubscribe at any time.